Tensegrity Pharma - Crunchbase Company Profile & Funding

Q: Where is Tensegrity Pharma's headquarters?

Tensegrity Pharma is located in Tokyo, Tokyo, Japan.

Q: Who invested in Tensegrity Pharma?

Tensegrity Pharma has 2 investors including Mitsubishi UFJ Capital And Newton Biocapital.

Q: When was the last funding round for Tensegrity Pharma?

Tensegrity Pharma closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Tensegrity Pharma raised to date?

Tensegrity Pharma has raised obfuscated.

Overview

Tensegrity Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Tensegrity Pharma

CB Rank

74407

Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.

Founded

obfuscation

Private

Seed

Tokyo, Tokyo, Japan

11-50

jp.tensegritypharma.com

Clinical Trials

Medical

Pharmaceutical

Funding Rounds

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Takahito Nakahara: Founder and CEO

Details

Legal Name

Tensegrity Pharma Co., Ltd.

Also Known As

テンセグリティファーマ

Operating Status

Active

Company Type

For Profit

Founders

Takahito Nakahara

About the Company

Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.

Phone Number

+81 03-6772-2938

Contact Email

info@tensegrityp.com

Predictions & Insights

Growth Insight

See this Growth Insight

Tensegrity Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

TSP-101

A therapeutic drug candidate designed to treat cachexia by blocking specific cancer-related signaling and inflammatory responses.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed
obfuscated obfuscation	Seed Round - Tensegrity Pharma	1	obfuscated obfuscation	Mitsubishi UFJ Capital	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Mitsubishi UFJ Capital	Yes	Seed Round - Tensegrity Pharma	—
Mitsubishi UFJ Capital	Yes	Seed Round - Tensegrity Pharma	—
Mitsubishi UFJ Capital	Yes	Seed Round - Tensegrity Pharma	—
Mitsubishi UFJ Capital	Yes	Seed Round - Tensegrity Pharma	—
Mitsubishi UFJ Capital	Yes	Seed Round - Tensegrity Pharma	—